{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:46:38Z","timestamp":1792169198990,"version":"4.4.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2026,11,5]]},"DOI":"10.1038\/s41416-026-03530-x","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:15:22Z","timestamp":1785849322000},"page":"1535-1543","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["AKR1B10 as a serum marker for diagnosis and postoperative monitoring of hepatocellular carcinoma"],"prefix":"10.1038","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9335-0381","authenticated-orcid":false,"given":"Ming","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaozhi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoluhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9357-3259","authenticated-orcid":false,"given":"Shunda","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5615-539X","authenticated-orcid":false,"given":"Deliang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"3530_CR1","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","volume":"16","author":"JD Yang","year":"2019","unstructured":"Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16:589\u2013604.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3530_CR2","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","volume":"79","author":"H Devarbhavi","year":"2023","unstructured":"Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. J Hepatol. 2023;79:516\u201337.","journal-title":"J Hepatol"},{"key":"3530_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7:6.","journal-title":"Nat Rev Dis Primers"},{"key":"3530_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41575-022-00688-6","volume":"20","author":"DQ Huang","year":"2023","unstructured":"Huang DQ, Mathurin P, Cortez-Pinto H, Loomba R. Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors. Nat Rev Gastroenterol Hepatol. 2023;20:37\u201349.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3530_CR5","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"3530_CR6","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/hep.31165","volume":"73","author":"JC Ahn","year":"2021","unstructured":"Ahn JC, Teng PC, Chen PJ, Posadas E, Tseng HR, Lu SC, et al. Detection of Circulating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular Carcinoma. Hepatology. 2021;73:422\u201336.","journal-title":"Hepatology"},{"key":"3530_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.soc.2023.06.005","volume":"33","author":"E Koo","year":"2024","unstructured":"Koo E, Singal AG. Hepatocellular carcinoma surveillance: evidence-based tailored approach. Surg Oncol Clin N Am. 2024;33:13\u201328.","journal-title":"Surg Oncol Clin N Am"},{"key":"3530_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.media.2021.101973","volume":"69","author":"H Sharma","year":"2021","unstructured":"Sharma H, Drukker L, Chatelain P, Droste R, Papageorghiou AT, Noble JA. Knowledge representation and learning of operator clinical workflow from full-length routine fetal ultrasound scan videos. Med Image Anal. 2021;69:101973.","journal-title":"Med Image Anal"},{"key":"3530_CR9","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.14309\/ajg.0000000000002774","volume":"119","author":"QF Chen","year":"2024","unstructured":"Chen QF, Chen S, Yi JZ, Wang JL, Zhong SX, Jiang XY, et al. Recommended 10-year follow-up strategy for small hepatocellular carcinoma after radiofrequency ablation: a cost-effectiveness evaluation. Am J Gastroenterol. 2024;119:2052\u201360.","journal-title":"Am J Gastroenterol"},{"key":"3530_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/hep.29831","volume":"68","author":"DE Kleiner","year":"2018","unstructured":"Kleiner DE. Hepatocellular carcinoma: Liver biopsy in the balance. Hepatology. 2018;68:13\u20135.","journal-title":"Hepatology"},{"key":"3530_CR11","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/hep.27563","volume":"61","author":"M Sherman","year":"2015","unstructured":"Sherman M, Bruix J. Biopsy for liver cancer: how to balance research needs with evidence-based clinical practice. Hepatology. 2015;61:433\u20136.","journal-title":"Hepatology"},{"key":"3530_CR12","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1053\/j.gastro.2018.04.027","volume":"155","author":"CE Costentin","year":"2018","unstructured":"Costentin CE, Layese R, Bourcier V, Cagnot C, Marcellin P, Guyader D, et al. Compliance with hepatocellular carcinoma surveillance guidelines associated with increased lead-time adjusted survival of patients with compensated viral cirrhosis: a multi-center cohort study. Gastroenterology. 2018;155:431\u201342.e10.","journal-title":"Gastroenterology"},{"key":"3530_CR13","doi-asserted-by":"publisher","first-page":"3928","DOI":"10.3748\/wjg.v21.i13.3928","volume":"21","author":"SI Seo","year":"2015","unstructured":"Seo SI, Kim HS, Kim WJ, Shin WG, Kim DJ, Kim KH, et al. Diagnostic value of PIVKA-II and alpha-fetoprotein in hepatitis B virus-associated hepatocellular carcinoma. World J Gastroenterol. 2015;21:3928\u201335.","journal-title":"World J Gastroenterol"},{"key":"3530_CR14","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/hep.24199","volume":"53","author":"J Bruix","year":"2011","unstructured":"Bruix J, Sherman M. American Association for the Study of Liver D. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020\u20132.","journal-title":"Hepatology"},{"key":"3530_CR15","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.bbrc.2009.06.123","volume":"387","author":"L Zhong","year":"2009","unstructured":"Zhong L, Liu Z, Yan R, Johnson S, Zhao Y, Fang X, et al. Aldo-keto reductase family 1 B10 protein detoxifies dietary and lipid-derived alpha, beta-unsaturated carbonyls at physiological levels. Biochem Biophys Res Commun. 2009;387:245\u201350.","journal-title":"Biochem Biophys Res Commun"},{"key":"3530_CR16","doi-asserted-by":"publisher","first-page":"11429","DOI":"10.1074\/jbc.273.19.11429","volume":"273","author":"D Cao","year":"1998","unstructured":"Cao D, Fan ST, Chung SS. Identification and characterization of a novel human aldose reductase-like gene. J Biol Chem. 1998;273:11429\u201335.","journal-title":"J Biol Chem"},{"key":"3530_CR17","doi-asserted-by":"crossref","unstructured":"Endo S, Matsunaga T, Nishinaka T The Role of AKR1B10 in physiology and pathophysiology. Metabolites. 2021;11.","DOI":"10.3390\/metabo11060332"},{"key":"3530_CR18","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.1074\/jbc.M707650200","volume":"283","author":"J Ma","year":"2008","unstructured":"Ma J, Yan R, Zu X, Cheng JM, Rao K, Liao DF, et al. Aldo-keto reductase family 1 B10 affects fatty acid synthesis by regulating the stability of acetyl-CoA carboxylase-alpha in breast cancer cells. J Biol Chem. 2008;283:3418\u201323.","journal-title":"J Biol Chem"},{"key":"3530_CR19","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.devcel.2014.04.025","volume":"29","author":"HF Hofbauer","year":"2014","unstructured":"Hofbauer HF, Schopf FH, Schleifer H, Knittelfelder OL, Pieber B, Rechberger GN, et al. Regulation of gene expression through a transcriptional repressor that senses acyl-chain length in membrane phospholipids. Dev Cell. 2014;29:729\u201339.","journal-title":"Dev Cell"},{"key":"3530_CR20","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1002\/mc.22844","volume":"57","author":"C Huang","year":"2018","unstructured":"Huang C, Cao Z, Ma J, Shen Y, Bu Y, Khoshaba R, et al. AKR1B10 activates diacylglycerol (DAG) second messenger in breast cancer cells. Mol Carcinog. 2018;57:1300\u201310.","journal-title":"Mol Carcinog"},{"key":"3530_CR21","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1158\/1078-0432.CCR-14-2072","volume":"21","author":"Y Shen","year":"2015","unstructured":"Shen Y, Ma J, Yan R, Ling H, Li X, Yang W, et al. Impaired self-renewal and increased colitis and dysplastic lesions in colonic mucosa of AKR1B8-deficient mice. Clin Cancer Res. 2015;21:1466\u201376.","journal-title":"Clin Cancer Res"},{"key":"3530_CR22","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/modpathol.2011.191","volume":"25","author":"YT Chung","year":"2012","unstructured":"Chung YT, Matkowskyj KA, Li H, Bai H, Zhang W, Tsao MS, et al. Overexpression and oncogenic function of aldo-keto reductase family 1B10 (AKR1B10) in pancreatic carcinoma. Mod Pathol. 2012;25:758\u201366.","journal-title":"Mod Pathol"},{"key":"3530_CR23","doi-asserted-by":"publisher","first-page":"E862","DOI":"10.1002\/ijc.27618","volume":"131","author":"J Ma","year":"2012","unstructured":"Ma J, Luo DX, Huang C, Shen Y, Bu Y, Markwell S, et al. AKR1B10 overexpression in breast cancer: association with tumor size, lymph node metastasis and patient survival and its potential as a novel serum marker. Int J Cancer. 2012;131:E862\u201371.","journal-title":"Int J Cancer"},{"key":"3530_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.727505","volume":"12","author":"Z Cao","year":"2022","unstructured":"Cao Z, Delfino K, Tiwari V, Wang X, Hannan A, Zaidi F, et al. AKR1B10 as a potential novel serum biomarker for breast cancer: a pilot study. Front Oncol. 2022;12:727505.","journal-title":"Front Oncol"},{"key":"3530_CR25","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1177\/147323001103900110","volume":"39","author":"MW Kang","year":"2011","unstructured":"Kang MW, Lee ES, Yoon SY, Jo J, Lee J, Kim HK, et al. AKR1B10 is associated with smoking and smoking-related non-small-cell lung cancer. J Int Med Res. 2011;39:78\u201385.","journal-title":"J Int Med Res"},{"key":"3530_CR26","doi-asserted-by":"publisher","first-page":"36733","DOI":"10.1074\/jbc.M113.514877","volume":"288","author":"D Luo","year":"2013","unstructured":"Luo D, Bu Y, Ma J, Rajput S, He Y, Cai G, et al. Heat shock protein 90-alpha mediates aldo-keto reductase 1B10 (AKR1B10) protein secretion through secretory lysosomes. J Biol Chem. 2013;288:36733\u201340.","journal-title":"J Biol Chem"},{"key":"3530_CR27","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1002\/hep.30519","volume":"69","author":"X Ye","year":"2019","unstructured":"Ye X, Li C, Zu X, Lin M, Liu Q, Liu J, et al. A large-scale multicenter study validates aldo-keto reductase family 1 member B10 as a prevalent serum marker for detection of hepatocellular carcinoma. Hepatology. 2019;69:2489\u2013501.","journal-title":"Hepatology"},{"key":"3530_CR28","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1007\/s00535-023-02011-9","volume":"58","author":"C Xie","year":"2023","unstructured":"Xie C, Ye X, Zeng L, Zeng X, Cao D. Serum AKR1B10 as an indicator of unfavorable survival of hepatocellular carcinoma. J Gastroenterol. 2023;58:1030\u201342.","journal-title":"J Gastroenterol"},{"key":"3530_CR29","doi-asserted-by":"publisher","first-page":"E183","DOI":"10.1111\/hepr.12942","volume":"48","author":"M Tsukamoto","year":"2018","unstructured":"Tsukamoto M, Nitta H, Imai K, Higashi T, Nakagawa S, Okabe H, et al. Clinical significance of half-lives of tumor markers alpha-fetoprotein and des-gamma-carboxy prothrombin after hepatectomy for hepatocellular carcinoma. Hepatol Res. 2018;48:E183\u2013E93.","journal-title":"Hepatol Res"},{"key":"3530_CR30","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/s41575-022-00620-y","volume":"19","author":"P Johnson","year":"2022","unstructured":"Johnson P, Zhou Q, Dao DY, Lo YMD. Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2022;19:670\u201381.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3530_CR31","doi-asserted-by":"publisher","first-page":"iv238","DOI":"10.1093\/annonc\/mdy308","volume":"29","author":"A Vogel","year":"2018","unstructured":"Vogel A, Cervantes A, Chau I, Daniele B, Llovet JM, Meyer T, et al. Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29:iv238\u2013iv55.","journal-title":"Ann Oncol"},{"key":"3530_CR32","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1053\/j.seminoncol.2012.05.001","volume":"39","author":"G Bertino","year":"2012","unstructured":"Bertino G, Ardiri A, Malaguarnera M, Malaguarnera G, Bertino N, Calvagno GS. Hepatocellualar carcinoma serum markers. Semin Oncol. 2012;39:410\u201333.","journal-title":"Semin Oncol"},{"key":"3530_CR33","doi-asserted-by":"crossref","unstructured":"Shi J, Liu J, Tu X, Li B, Tong Z, Wang T, et al. Single-cell immune signature for detecting early-stage HCC and early assessing anti-PD-1 immunotherapy efficacy. J Immunother Cancer. 2022;10.","DOI":"10.1136\/jitc-2021-003133"},{"key":"3530_CR34","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/hep.32779","volume":"78","author":"YT Lee","year":"2023","unstructured":"Lee YT, Fujiwara N, Yang JD, Hoshida Y. Risk stratification and early detection biomarkers for precision HCC screening. Hepatology. 2023;78:319\u201362.","journal-title":"Hepatology"},{"key":"3530_CR35","doi-asserted-by":"crossref","unstructured":"Faccia M, Garcovich M, Ainora ME, Riccardi L, Pompili M, Gasbarrini A, et al. Contrast-Enhanced Ultrasound for Monitoring Treatment Response in Different Stages of Hepatocellular Carcinoma. Cancers (Basel). 2022;14.","DOI":"10.3390\/cancers14030481"},{"key":"3530_CR36","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3350\/cmh.2023.0102","volume":"29","author":"H Koga","year":"2023","unstructured":"Koga H, Iwamoto H, Suzuki H, Shimose S, Nakano M, Kawaguchi T. Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Japanese perspective. Clin Mol Hepatol. 2023;29:242\u201351.","journal-title":"Clin Mol Hepatol"},{"key":"3530_CR37","unstructured":"European Association for the Study of the L. EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma. J Hepatol. 2025;82:315\u201374."},{"key":"3530_CR38","doi-asserted-by":"publisher","first-page":"460","DOI":"10.4254\/wjh.v15.i4.460","volume":"15","author":"YX Gao","year":"2023","unstructured":"Gao YX, Ning QQ, Yang PX, Guan YY, Liu PX, Liu ML, et al. Recent advances in recurrent hepatocellular carcinoma therapy. World J Hepatol. 2023;15:460\u201376.","journal-title":"World J Hepatol"},{"key":"3530_CR39","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1042\/BJ20110111","volume":"438","author":"DX Luo","year":"2011","unstructured":"Luo DX, Huang MC, Ma J, Gao Z, Liao DF, Cao D. Aldo-keto reductase family 1, member B10 is secreted through a lysosome-mediated non-classical pathway. Biochem J. 2011;438:71\u201380.","journal-title":"Biochem J"},{"key":"3530_CR40","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.humpath.2013.12.002","volume":"45","author":"KA Matkowskyj","year":"2014","unstructured":"Matkowskyj KA, Bai H, Liao J, Zhang W, Li H, Rao S, et al. Aldoketoreductase family 1B10 (AKR1B10) as a biomarker to distinguish hepatocellular carcinoma from benign liver lesions. Hum Pathol. 2014;45:834\u201343.","journal-title":"Hum Pathol"},{"key":"3530_CR41","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.jhep.2018.10.022","volume":"70","author":"G Marasco","year":"2019","unstructured":"Marasco G, Colecchia A, Colli A, Ravaioli F, Casazza G, Bacchi Reggiani ML, et al. Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection. J Hepatol. 2019;70:440\u20138.","journal-title":"J Hepatol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03530-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03530-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03530-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:57:21Z","timestamp":1792166241000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03530-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,11,5]]}},"alternative-id":["3530"],"URL":"https:\/\/doi.org\/10.1038\/s41416-026-03530-x","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"assertion":[{"value":"4 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Informed consent was obtained from all authors.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This study was approved by the Medical Ethics Committee of Hunan Cancer Hospital and the Medical Ethics Committee of Hunan Provincial People\u2019s Hospital, conformed to ethical guidelines of the Declaration of Helsinki. Informed consents were obtained from participants.","order":3,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}